After careful consideration, we have made the very difficult decision to switch ICNMD2021 to a virtual format. Although we were very much looking forward to welcoming you to Valencia, asking you all to travel to Spain and attend in person this May was just too soon. Even with the start of delivery of vaccines, the confidence to travel safely abroad with all the continued uncertainty, we felt this to be the most responsible path for ICNMD and all its stakeholders. The health and safety of the entire ICNMD community is of the utmost importance and is what drove our decision at this time.

Thanks to the superb work of the Scientific and Program Committees and the cooperation of institutions like SEN, WFN, PNS, ENMC, ERN-EURO-NMD and many others, an attractive scientific program for the Congress was built that far surpassed expectations. In fact, the number and quality of abstract submissions, the number of registrations and the offer of parallel activities by pharmaceutical companies for the 2021 Congress broke records. We can only wish to convey our gratitude to all who supported us. We also must recognize the great contribution by the SGS team for their logistics and technical assistance.

We are now very excited to announce ICNMD2021 will be virtual and will take place on 21 - 22 & 28 - 29 May 2021. In the coming weeks, we will be working hard to build you an engaging virtual program as well as provide updates on registration and new sponsorship opportunities. While we will not get to meet in person, we look forward to providing a virtual experience that is accessible worldwide and to enable attendees to connect and access the latest research through a new format.

In the coming weeks, we will be contacting our speakers, sponsors and registered delegates to help with a smooth transition to the virtual meeting.

We thank you once again for your continued interest in ICNMD, and we hope you will join us virtually this May!

Sincerely,